This would represent a new record for a pharmacological agent if confirmed in Phase 3
Semaglutide is a synthetic glucagon-like peptide-1 (GLP-1) receptor agonist developed for the treatment of type 2 diabetes and obesity
This dual action, combined with reduced food intake, helps prevent high blood sugar spikes, which is beneficial for patients at risk of diabetes or cardiovascular disease
Many people are saying yes. Online, social media influencers tout vials of substances with names like BPC-157 or Sermorelin, promising great skin, a lean body or easy muscle recovery
This is just the newest iteration of marketing that is out there to try and maintain profit. Consumers should be on alert because its a matter of time before it gets abused, Fadul noted
They review the whole health picture, including: Blood pressure Blood sugar Weight trends Family history Smoking history Inflammation history Current medications Kidney and liver health Heart symptoms Why GLP-1 Drugs May Help the Heart Researchers continue to study how GLP-1 medicines may support heart health
)
